Date: July 27, 2021
Time: 8:00am (PDT), 11:00am (EDT)
The Origin of Biopharmaceutics (Biopharma) derive from The Division of Clinical Research in the U.S. Bureau of Medicine. However, authority is vested in the Division of Biopharmaceutics within the U.S. Food & Drug Administration (FDA), and so if generally considered as official onset of this field of expertise. Shortly after, bedrock concepts and parameters were developed and published. Topics ranging from pharmacokinetics and drug metabolism to bioavailability and bioequivalence were established. It is at this point where protocols and regulatory considerations for Scale-Up of Biologics also began. By extension, this is also the point where many challenges in scaling up/out are rooted.
- Identify techniques for scale-up/out of production of biologics.
- Discuss the associated challenges with scale-up/out of biologics.
- Explain how to isolate and characterize exosomes.
- State ways to improve purity and yields in exosome harvesting.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.